Patient nostril microbial flora: individual-dependency and diversity precluding prediction of Staphylococcus aureus acquisition  by Alvarez, A.S. et al.
Patient nostril microbial flora: individual-dependency and diversity
precluding prediction of Staphylococcus aureus acquisition
A. S. Alvarez1,2, L. Remy1,2, C. Allix-Beguec3, C. Ligier4,5, C. Dupont4,5,6, O. Leminor4,5,6, C. Lawrence1,2, P. Supply3,7,8,9,10,
D. Guillemot4,5,6,11, J. L. Gaillard1,2, J. Salomon4,5,12 and J.-L. Herrmann1,2
1) University of Versailles St Quentin in Yvelines and UFR des Sciences de la Sante, Montigny le Bretonneux, 2) Assistance Publique - Ho^pitaux de Paris, Raymond
Poincare Hospital, Microbiology Laboratory, Garches, 3) Genoscreen, Institut Pasteur, Lille, 4) Pharmaco-epidemiology and Infectious Diseases Unit, Pasteur
Institute, 5) Inserm, U657 Unit, Paris, 6) University of Versailles St Quentin in Yvelines and UFR des Sciences de la Sante, Montigny le Bretonneux,
7) INSERM, U1019 Lille, 8) CNRS UMR 8204, Lille, 9) Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, 10) University Lille Nord de
France, Lille, 11) Assistance Publique–Hoˆpitaux de Paris, Raymond-Poincare´ Hospital, Unite de Sante´ Publique, Garches and 12) Conservatoire National des Arts
et Me´tiers, Laboratoire Mode´lisation Epide´miologie et Surveillance des Risques Sanitaires, Paris, France
Abstract
The potential role of a patient’s resident microbial flora in the risk of acquiring multiresistant bacteria (MRB) during hospitalization is
unclear. We investigated this role by cross-sectional study of 103 patients at risk of acquisition of Staphylococcus aureus (SA), resistant
(MRSA) or not (MSSA) to methicillin, recruited in four French hospitals. The flora was analysed by an exhaustive culture-based approach
combined with molecular and/or mass-spectrometry-based identification, and SA strain typing. Forty-three of the 53 SA-negative patients at
entry were followed for up to 52 weeks: 19 (44.2%) remained negative for SA and 24 (55.8%) became positive, including 19 (79%) who
acquired an MSSA, four (17%) who acquired an MRSA and one who acquired both (4%). Fifty-one different species were identified among
the 103 patients, of which two, Corynebacterium accolens and Staphylococcus haemolyticus (p = 0.02-0.01), were more prevalent in the absence
of SA. However, the same number of patients carrying or not these two species acquired an MSSA/MRSA during follow-up, regardless of
antibiotic treatment received. Clustering analysis showed that the microbial flora was highly specific to each patient, and not predictive for
acquisition of MSSA/MRSA or not. Patient-specific microbial resident flora is not predictive of SA acquisition.
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Introduction
Antimicrobial resistance has become a central challenge in the
control of infectious diseases, especially in hospitals [1,2].
Strategies to prevent nosocomial infection will be more
effective if they are guided by a comprehensive knowledge of
risk factors determining the acquisition of these agents by the
hospitalized patient. Such knowledge is especially pertinent
when the same agents also exist in the community [3] or are
widespread in some populations [3], rendering sourcing of the
patient colonization more difficult.
Important risks factors, such as advanced age, underlying
diseases and severity of illness, and inter-institutional transfer of
patients proved to be common and universal whatever the agents
[4].However, thepotential natural protectiondevelopedbyhosts
might also play an important role, by limiting the success of
colonization by MRB in their own ecosystem. This question still
needs to be addressed: studies examining in particular the role of
host factors in SA acquisition are still scarce, especially with
regards to SA nasal carriage [5,6]. Two main mechanisms are
putatively involved: host factors or immunity [7–9], whether
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acquired [10] or innate [11], and the barrier effect of themicrobial
resident flora (also termed bacterial interference) [12–16].
Uncertainties still persist regarding a potential barrier effect
of the resident nostril microbial flora in preventing SA
acquisition, despite the identification of several genus/species
potentially involved [12–16]. The barrier effect of these genus/
species during follow-up of na€ıve SA patients is still not known.
In addition, published studies mostly involved healthy subjects
only, rarely patients [16]. No longitudinal studies had been yet
conducted on a hospitalized patient population who are also at
risk of SA acquisition.
Here, we investigated the potential role of the resident
nostril microbial flora in SA acquisition, by analysing the nostril
flora of 103 handicapped patients with neurological disorders.
These patients, hospitalized for a long period of time in four
rehabilitation centres, often suffered from multiple infectious
complications and, as a consequence, received many
broad-spectrum antibiotics, providing a favourable environ-
ment for detecting stochastic acquisition of MSSA/MRSA and
parameters involved. We undertook a systematic quantifica-
tion of any isolated bacteria from a nasal swab taken from
patients at inclusion and during the follow-up for patients’
na€ıve for SA colonization at inclusion.
Materials and Methods
Epidemiological study
Our studywas performed from January 2008 toDecember 2010
as part of a clinical research programme named ASAR (detailed
in Supplementary Data) in four French hospitals. Patients were
asked and gave full consent to participate in the ASAR project.
The first 103 recruited patients screened for nasal SA before
inclusion, had their nasal swab also used for analysis of their
microbial flora. This group comprised 50 patients that were
positive and 53 patients that were na€ıve for SA carriage at entry.
The 53 SA-na€ıve patients were then followed-up for 13 weeks if
they did not acquire an SA and 52 weeks in the case of SA
acquisition (Supplementary Figure 1).
Nasal swab collection and culture for SA detection
Alginate swabs, soaked beforehand in sterile physiological
saline solution, were rotated five times around the inside of
both nostrils while applying constant pressure. Swabs were
then placed in Stuart’s transport medium (500 ll, Transwab,
Medical Wire and Equipment, Corsham, Wiltshire, England)
and kept at room temperature until arrival at the Microbiology
Laboratory (Raymond Poincare Hospital, Garches, France).
A 100-ll aliquot was plated on selective and non-selective
media for MSSA/MRSA isolation as detailed in Supplementary
Data. The rest of the heavy dispersed suspension was then
stored at 80°C for further use. Screening for MRSA and
antimicrobial susceptibility testing were performed as detailed
in Supplementary Data.
Culture and quantification of the microbial flora
One hundred-microlitre aliquots were serially diluted up to
104 and plated on different selective and non-selective media
(resulting in 16 conditions per patient, see supplementary
figure 2), and incubated at 37°C in aerobic  5% CO2 and
anaerobic conditions. Plates were read at 24 h and 48 h after
incubation (see Supplementary Data).
MALDI-TOF and molecular species identification of isolated
bacteria
Matrix-assisted laser desorption/ionisation-time-of-flight mass
spectrometry (MALDI-TOF) and/or DNA sequencing were
used for specific identification as previously described [17,18].
Spa-typing of SA isolates
Spa typing was performed as previously described [19] and is
summarized in Supplementary Data.
Clustering-based analyses of composition of nostril flora
For each patient, each of the species isolated from the
microbial nostril flora, or of the 16 most represented species,
was coded 1 when present or 0 when absent. The resulting
flora composition fingerprints were then used in the Bionum-
erics 6.5 software (Applied Maths) as strings of categorical
characters to construct minimum spanning trees, in order to
analyse the clustering of SA and non-SA carriers according to
the flora composition.
Statistical analysis
T-tests for independent samples, using R software, and logistic
regression, using Stata software (Data analysis and Statistical
Software, TX, USA), were utilized in univariate and multivariate
models to evaluate probability for differences between patients
who were SA carriers or non-carriers (see Supplementary
Data); p  0.05 was considered statistically significant.
Results
Quantitative comparison of the SA+ and SA patient
population
The 103 patients included in the study were all disabled,
requiring extensive medical and nursing care, leading to
bacterial over-exposure (Table 1). Patients had bedsores and
close regular contacts with nursing and physiotherapy staff, and
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underwent intermittent bladder catheterization and other
invasive procedures several times per day. Each of these
characteristics represents a high risk factor for the acquisition
of MRB.
Fifty out of the 103 patients were positive for SA carriage
and 53 were negative. The 50 carriers comprised 36 MSSA
(72%) and 14 MRSA (28%). SA isolates were classified into 15
different spa-types (Fig. 1). The most represented spa-types
were t008, t777 and t002. MRSA types were represented by
three spa-types only, of which a single one was MRSA specific
(t6442).
The number of species per nostril specimen was significantly
higher among the 53 non-SA carriers (Table 2A). A similar
trend towards a higher number of different species was
observed among the 36 MSSA-positive patients compared with
the 14 MRSA-positive patients, although this difference was
not significant (p 0.15; Table 2B).
Fifty-one different species were identified at the species
level, independently of the SA status, with a majority of
Gram-positive bacteria (89%). The mean CFU/ml of all isolated
species was not significantly different between the 53 non-SA
and 50 SA carriers (5.3 9 105 and 8.6 9 105, respectively;
p 0.25).
The 50 SA carriers possessed less Gram-positive rods
(p 0.031) and more Gram-positive cocci (p 0.019; Fig. 2a).
The difference in Gram-positive rods was mostly attributable to
the 36 MSSA-positive patients (p 0.015; Fig. 2b), and essentially
reflected a lower proportion of Corynebacteriaceae in this group
of patients, compared with the 53 non-SA carriers (p 0.05;
Fig. 2c). A difference in Corynebacteriaceae frequency was also
seen when comparing the 14 MRSA-positive patients and the 53
non-SA carriers, albeit not reaching significance. Likewise, the 36
MSSA-positive patients possessed more Gram-positive cocci
compared with the 14 MRSA-positive patients (p 0.037) or the
53 non-SA carriers (p 0.002; Fig. 2b). At the genus level, the
nostril composition of Staphylococcaceae differed only between
the 36 MSSA-positive patients and the 53 non-SA carriers
(p 0.002; Fig. 2c).
Of interest, an increase in the presence of Enterobacteriaceae
was observed only in the 14MRSA carrierswhen comparedwith
the 36 MSSA-positive patients (p 0.0047; Fig. 2c).
Species composition in SA and non-SA carriers
Analysis of the nostril microbial flora demonstrated a clear
variety at the species level (Table 3), with an over-represen-
tation of Staphylococcus epidermidis (93.2%), and a good
representation of Corynebacterium accolens (43.7%) and Propi-
onibacterium spp (29.1%). Only C. accolens and S. haemolyticus
were more significantly prevalent (but not exclusively) among
the 50 non-SA patients (Table 3).
A clustering approach for analysing nostril microbial flora of
SA and non-SA carriers at inclusion
We used a clustering-like approach to identify signatures that
might allow the prediction of SA carriage. The minimum-span-
ning tree obtained (with exclusion of SA) demonstrated a great
diversity, with at least 80 different patterns among the 103
patients (Fig. 3a). None was correlated with the SA carrier
status, as several microbial flora compositions were identical
between some SA + or SA carriers and no obvious groupings
TABLE 1. Socio-demographic and therapeutic characteristics of the 103 patients
S. aureus colonization
Univariate analysis
Yes (n = 50)
No (n = 53) Total (n = 103)
MSSA
(n = 34)
MRSA
(n = 16)
Measurement n % n % N N % N Odds ratio IC 95 % p- valuea
Age (years) 48.8b  17.7c 49.5b  15.1c 47.8b  15.7c 0.77 0.24–2.49 0.92
Sex 0.78
Female 9 26.5 3 18.8 12 14 26.4 26 0.88 0.36–2.14
Male 25 73.5 13 81.3 38 39 73.6 77 Ref.
Skin lesions 0.35
Yes 12 35.3 7 43.8 19 25 47.2 44 0.69 0.32–1.51
No 22 64.7 9 56.3 31 28 52.8 59 Ref.
Medical devices 0.40
Yes 11 32.4 7 43.8 18 15 28.3 33 1.43 0.62–3.27
No 23 67.7 9 56.3 32 38 71.7 70 Ref.
Allergy 0.30
Yes 4 11.8 1 6.2 5 9 17.0 14 0.54 0.17–1.75
No 30 88.2 15 93.8 45 44 83.0 89 Ref.
Smoking 0.87
Yes 4 11.8 3 18.8 7 7 13.2 14 1.10 0.35–3.39
No 30 88.2 13 81.3 43 46 86.8 88 Ref.
aLogistic regression between S. aureus-colonized patients (n = 50) and non-colonized patients (n = 53).
bMean.
cStandard deviation.
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of different but related strain compositions (i.e. differing by
one or two species at most) were detected according to the
carrier status (i.e. no visible trend for grouping identically
coloured circles in Fig. 3a). This was also shown by the
observation that, when SA was included in the analysis, it
separated almost perfectly the SA+ and SA carriers,
reflecting the fact that SA presence actually represented the
sole major ‘allele’ shared by the SA+ population and system-
atically absent from the SA population (Supplementary Figure
3A). A similar trend was observed when using only the 16
most prevalent species in order to reduce the weight of
‘absent species’ alleles in composition fingerprints (Fig. 3b and
Supplementary Figure 3B).
Nostril microbial flora and SA acquisition during follow-up
Twenty-four out of 43 patients (55.8%) (10 exclusions,
supplementary figure 1) became SA positive, with a medium
time for acquisition of 7 weeks, and 19 out of 43 patients
(44.2%) did not acquire SA during the 13-week follow-up. A
similar therapeutic strategy was observed in both populations
(not shown). Nineteen patients out of the 24 acquired an
TABLE 2. Number of bacterial species per patient nostril
microbial flora in SA carrier vs. non-SA carrier (A) and in
MSSA-positive vs. MRSA-positive patients (B)
A. Number of bacterial species present in nostril flora
S. aureus
colonization
0 1 2 3 4 5 6 7 8 mean p-value
No (n = 53) 0 3 14 7 8 9 8 1 3 3.92 0.002
Yes (n = 50) 1 10 12 12 6 6 2 1 0 2.9
B. Number of bacterial species present in nostril flora
S. aureus
colonization
0 1 2 3 4 5 6 7 mean p-value
MSSA
(n = 34)
1 7 11 7 4 2 1 1 2.6 0.15
MRSA
(n = 16)
0 3 1 5 2 4 1 0 3.3
FIG. 1. Distribution of S. aureus spa-types in the nostril flora of patients. Minimum spanning tree (MST) analysis of 50 SA nostril isolates from
patients based on spa-types. Each circle represents a spa-type, and the size of the circle corresponds to the number of isolates. Bold line connects
spa-types that differ by one repeat unit motives. The fine line connects spa-types that differ by two repeat unit motives, bold dotted line indicates
three repeat unit motives and other dotted lines more than three repeat unit motives. The red colour represents MSSA and purple is used for the
characterization of MRSA.
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MSSA (79%), four an MRSA (17%) and one both an MSSA and
MRSA (4%). In total, spa typing among the 35 SASM and 7
SARM isolates obtained for these 24 patients during follow-up
demonstrated 13 different spa-types, with similar predominant
spa-types seen at inclusion.
We compared the microbial flora between inclusion (S0)
and 1 week before acquisition (S1), between S1 and
acquisition (S), and between S and 1 week after acquisition of
SA (S+1). As in the above situation, univariate and multivariate
analysis and clustering analysis did not identify significant
differences among flora compositions allowing prediction of
SA, MSSA or MRSA carriage at any step. Groups were too
small to achieve significance (not shown).
Discussion
The potential role of the resident nasal microbial flora in
preventing or favouring SA establishment in the nares remains
unclear. In particular, this potential role had not previously
been examined in high-risk patients facing a long hospitalization
and high antibiotic pressure.
Our results show that in such a patient population,
resident flora are diverse and tend to be strongly individ-
ual-dependent, and none of the resident flora (other than
SA) allows differentiation between SA-positive and SA-neg-
ative patients, and prediction of acquisition of sensitive or
resistant SA.
However, we observed variations of composition among
patient groups, though not in terms of abundance. We did not
see any significant CFU count differences for any isolated
species between SA+ and SA patients. Instead, the main
significant difference was in the number of bacterial species
present in the nostril per specimen, with more numerous and
different species in the absence of SA carriage. This result is
consistent with the expected competition in the nostril flora,
where the absence of a species is compensated for by the
presence of other species.
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FIG. 2. Composition of the microbial nostril flora varied between SA and non-SA carrier patients. (a) Representation of the composition of microbial
nostril flora for SA and non-SA carrier patients. (b) Composition of microbial nostril flora differentiating patients with MSSA and MRSA. (c)
Representation of bacterial families in nostril flora of MSSA, MRSA and non-carrier patients. Statistical analysis was performed with Fisher’s exact test.
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Corynebacterium accolens and S. haemolyticus were found to
be present in the resident flora in the absence of SA at a
significantly higher level. Identification of C. accolens has not
been carried out at the species level in previous studies using
phenotypic or metagenomic methods [12,13,16] but could be
achieved here by using Maldi-Tof and rpoB sequence analysisT
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FIG. 3. Nostril flora profile excluding the presence of SA. A
minimum spanning tree (MST) analysis was generated by BioNumerics
software (version 6.5; Applied Maths) and based on the microbial
composition of nostril flora of SA carrier and non-SA carrier patients.
The red colour represents nostril floral with MSSA, purple represents
nostril flora with MRSA and green represents nostril flora without
S. aureus. (a) Repartition of nostril flora with the 51 represented
species and excluding the SA presence in the algorithm. (b) Repartition
of nostril flora with only the 16 most prevalent bacterial species
excluding the presence of SA in the algorithm.
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[17]. C. accolens, a resident of the upper respiratory tract,
shows satellite growth around SA streaks on blood agar
[20,21]. It is also a recently isolated pathogen, described in a
recent case of a breast abscess [22] and pelvic osteomyelitis
[23].
Staphylococcus haemolyticus was the exclusive Gram-posi-
tive cocci present in non SA-carriers. S. haemolyticus is highly
prevalent in the hospital environment [24] and is the second
most frequent SCN isolated from blood cultures [24].
S. haemolyticus is notorious for its multiresistance [25–27]
and the presence of many antibiotic resistance genes in its
genome [28]. Additionally, S. haemolyticus possess several
factors helping colonization of the human host [28]. These
elements are thus consistent with its frequent isolation from
hospitalized patients in the present study.
We also observed differences between MSSA and MRSA
carriers, not investigated previously [12–16]. In fact, MSSA
carrier flora differed from MRSA carrier flora, mainly by the
Gram-positive cocci composition, which represented a differ-
ence almost equal to the difference observed between MSSA
and non-SA carriers.
However, despite these unequal distributions among
patient groups, our follow-up design allowed us to show
that the number of patients acquiring SA during follow-up
and with or without C. accolens or S. haemolyticus was not
significantly different. This result, not found previously,
confirms that a unique time-point comparison does not
predict a role in favour of SA colonization for C. accolens and/
or S. haemolyticus or otherwise. None of the differences
related to antimicrobial consumption or to microbial flora
composition before detection of SA carriage allowed the
prediction of subsequent SA acquisition. This absence of a
predictive influence points to a major role of factors other
than the microbial flora in SA acquisition; these might include
the patient’s local environment and/or the immune status of
the carrier.
This study has some limitations. We used exhaustive
culture-based methods for bacterial identification, but not a
metagenomic approach to identify non-cultivable species.
However, the latter approaches, especially when targeting
16S rDNA amplification/sequencing or correlating the
respective frequencies of sequence reads from each organism
and the amount of organism, have many drawbacks for the
identification and quantification of the microbial species
present in a microbial flora, as reported recently [29]. In
contrast, we were able to quantify globally and individually
each species detected in the nostril flora, and did not see any
significant CFU count differences for any isolated species
from both SA+ and SA patients. We even detected several
bacterial species with a concentration in the range of
102 CFU/ml (not shown), below the usual detection thresh-
olds of metagenomic approaches [16]. In addition, we note
that none of the major species previously found by metage-
nomic analysis of nostril flora [16] was missed in our study,
indicating the sensitivity of our serial dilutions and the
relevant choice of culture media. Compared with classical
metagenomics solely targeting 16S rDNA, we were likely to
be more precise in terms of species identification by using a
combination of several molecular targets and MALDI-TOF--
based analysis [17,18], leading, for example, to the identifi-
cation of Corynebacteriaceae at a species level. We believe
therefore that our approach might serve as a potential
reference standard for further development of metagenomics
to characterize the dynamics of nostril flora.
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